Tetra Bio Pharma Inc (TBPMQ)

[MrCheap]

National Investor just put a new recommendation to accumulate Tetra Bio-Pharma.
https://www.facebook.com/TheNationalInvestor
__________________________________________________

As I wrote to you soon after I was at this year's Orlando Money Show back closer to the beginning of the year, I've been attempting to increase my learning curve where the promising but risky cannabis/medical marijuana industry is concerned. I've been fascinated by a lot of what I've been learning; and have also been chagrined at coming to understand the smoke and mirrors of many companies' illegitimate or disingenuous claims of what they purport to have or be working on.

I've commented about how, to me, this industry is much like the Internet and dot-com one that began to emerge back in the 1990's. The majority of the early companies in that nascent industry are no more. The same will one day be true here as well; the great majority of the cannabis-related companies beating your door down or piling up unread e-mails on your computer will likewise become extinct.

But the industry itself and the science IS legit. I know people personally who have benefited greatly from one form of medical marijuana or cannabis oil-laced (as opposed to hemp) concoction or another. No question there.

Not that there are no other good companies out there; I continue to read up on several, as I whittle down my own list. But for today I'm bringing you one I have been following since last Fall and am ready to advocate pulling the trigger on:

New Recommendation: Tetra Bio-Pharma, Inc. (TSXV-TBP; OTC-GRPOF) -- Today's open: C70 cents/share (US52 cents/share)

The company then still known as Grow-Pro Ventures (it went through a company "makeover" of sorts just afterward) was first introduced to me by its C.F.O. Sabino DiPaola last September, when he was also in Quito, Ecuador. Sabino also serves as C.F.O. for Cornerstone Capital Resources.

I don't recall just how the subject came up. But however it did, Sabino wanted me to be sure to take a close look at Tetra in my search for legitimate opportunities in the emerging cannabis industry, and explained several reasons why it was worth my scrutiny.

One key reason for Tetra's spike earlier this year was as the Phase I process with the U.S. Food and Drug Administration was preparing to get underway for the company's Patent-pending, novel smokable medical marijuana. The MUCH-better known company in this industry, GW Pharmaceuticals, plc (NASD-GWPH) is presently in trials with a smokable product in the U.K., but narrowly focused on the epilepsy and multiple sclerosis area.

It has a market cap of a bit shy of $3 billion (U.S.)

Tetra Bio-Pharma, on the other hand, is focusing on the much broader cancer market (primarily) with its offering. It is relatively undiscovered still (though a couple key, larger players have been brought into the mix as major investors in TBP and more.)

Tetra's market cap is about C$80 million; or roughly US$58 million.

Though the Trump Administration (and especially A.G. Jeff Sessions) has shown little interest in any recreational use of smoked marijuana gaining any acceptance in the U.S., the president especially has been supportive of legitimate medical usage. That in one form or another is now legal in about 30 states; and pretty much nation-wide in Canada, marijuana has gained acceptance.

I'll have more to say on Tetra in the next expanded issue, once I am back home from my northern trek (where, as I mentioned the other day, I also visited with an oldie but goodie, PolyMet Mining.)

For now, though, digest that disparity above. . .

Check out the company's very informative web site at http://tetrabiopharma.com/ . . .

AND check out this article and interview with Tetra's Chief Science Officer, Dr. Guy Chamberland.

Tetra Bio-Pharma is started as an "Accumulate" and added to my stable of Speculative opportunities. As you see above, it has consolidated in a narrow range between C60 - C70 cents a share of late, one which should prove a new, higher foundation for more strength as additional news comes out down the road.

All the best,
Chris Temple -- Editor/Publisher
The National Investor
http://nationalinvestor.com/

You can get information anywhere. Here, you get knowledge.